Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor

Matteo Ferro(European Institute of Oncology), Giuseppe Lucarelli(University of Bari Aldo Moro), Marco Borghesi(University of Bologna), Walter Artibani(University of Padua), Rocco Damiano(Magna Graecia University), Carlo Buonerba(CTO Andrea Alesini), Sisto Perdonà(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Daniela Terracciano(Federico II University Hospital), Michele Battaglia(Mater Dei Hospital), Nicolae Crişan(Iuliu Hațieganu University of Medicine and Pharmacy), Angelo Porreca(Istituto Oncologico Veneto), Gennaro Musi(University of Milan), Pasquale Ditonno(University of Bari Aldo Moro), Ottavio De Cobelli(University of Milan), Giorgio Ivan Russo(European Association of Urology), Savino M. Di Stasi(University of Rome Tor Vergata), Gian Maria Busetto(Sapienza University of Rome), Riccardo Autorino(Rush University Medical Center), Guru Sonpavde(AdventHealth Orlando), Giuseppe Di Lorenzo(Saint Camillus International University of Health and Medical Sciences), Estêvão Lima(University of Minho), Mihai Dorin Vartolomei(University of Bern), Paola Del Prete(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Pierluigi Bove(University of Rome Tor Vergata), Martha Orsolya Katalin(Universitatea de Medicină, Farmacie, Științe și Tehnologie „George Emil Palade” din Târgu Mureș), Francesco Cantiello(Magna Graecia University), Rodolfo Hurle(IRCCS Humanitas Research Hospital), Abdal Rahman Abu Farhan(Magna Graecia University), Francesco Del Giudice(Sapienza University of Rome), Raluca Marian(Universitatea de Medicină, Farmacie, Științe și Tehnologie „George Emil Palade” din Târgu Mureș), Giorgio Guazzoni, Vincenzo Mirone(University of Naples Federico II), Vincenzo Serretta(University of Palermo)
Urologic Oncology Seminars and Original Investigations
March 12, 2020
Cited by 48


Related Papers